Wish I had read this information before I brought in at .77 last week. I hope im wrong as I cant see were Moxduo has a safety advantage over the two individual doses. That seems to be the sticking point. We just jiggle around the results and still it fails to be a safety advantage. If It were me I would say no as it still doesn't clearly satisfy the dual drug law, compared to individual doses. It may be more convenient but they cant really prove any synergies.
Shit
Fingers crossed
Graeme
- Forums
- ASX - By Stock
- palms are sweaty
Wish I had read this information before I brought in at .77 last...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)